MyLungCancerTeam

For stage 3A non-small cell lung cancer (NSCLC), the remission rates can vary based on several factors, including the specific treatments received. Here are some key points from my knowledge base:

- Surgery (Lobectomy): Removing the tumor surgically is a common first step
- Chemotherapy: Often used to kill any remaining Show Full Answer

For stage 3A non-small cell lung cancer (NSCLC), the remission rates can vary based on several factors, including the specific treatments received. Here are some key points from my knowledge base:

- Surgery (Lobectomy): Removing the tumor surgically is a common first step.
- Chemotherapy: Often used to kill any remaining cancer cells.
- Targeted Therapy (Tagrisso): Used for tumors with EGFR mutations, can help in prolonging progression-free survival.

While specific remission rates aren't provided, it's important to note that targeted therapies like Tagrisso have shown to increase progression-free survival. For instance, a study mentioned in my knowledge base showed a median progression-free survival of 18.9 months for people with non-small cell lung adenocarcinoma treated with targeted therapy.

Your oncologist can provide more personalized information based on your specific case and treatment response.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Lung Cancer Remission: 6 Facts To Know | MyLungCancerTeam

Stage 3 Lung Cancer: What To Expect | MyLungCancerTeam